脂蛋白颗粒谱、标准血脂与外周动脉疾病发病风险
结果显示,LDL胆固醇与PAD无关,而总和小LDL颗粒、极低密度脂蛋白颗粒亚类、总胆固醇与高密度脂蛋白胆固醇比值(TC:HDL-C)及低HDL颗粒浓度与PAD风险显著相关。
要点
- LDL胆固醇水平与症状性PAD发病无显著关联。
- 总LDL颗粒和小LDL颗粒浓度升高与PAD风险增加相关。
- TC:HDL-C、VLDL颗粒亚类升高及HDL颗粒浓度降低亦为PAD风险决定因素。
核心结论
- 核磁共振衍生的LDL颗粒而非LDL胆固醇与症状性PAD发病相关。
- 致动脉粥样硬化性血脂异常的其他特征,包括TC:HDL-C升高、富含甘油三酯脂蛋白升高及HDL标准与颗粒测量降低,是PAD的显著风险决定因素。
主要发现
- 年龄校正分析中,LDL胆固醇与PAD无关,而总和小LDL颗粒浓度、甘油三酯、VLDL颗粒亚类浓度、TC:HDL-C升高、低HDL-C及低HDL颗粒浓度与PAD显著相关(极端三分位比较P均<0.05)。
- 多变量校正模型中,极端三分位比较:总LDL颗粒调整后风险比(HRadj)2.03(95%CI 1.14-3.59),小LDL颗粒HRadj 2.17(95%CI 1.10-4.27),极大型VLDL颗粒HRadj 1.68(95%CI 1.06-2.66),中型VLDL颗粒HRadj 1.98(95%CI 1.15-3.41),TC:HDL-C HRadj 3.11(95%CI 1.67-5.81)。
- HDL与风险呈负相关:HDL-C极端三分位HRadj 0.30(P趋势<0.0001),HDL颗粒浓度HRadj 0.29(P趋势<0.0001)。
- 小LDL颗粒、中型和极大型VLDL颗粒、TC:HDL-C、HDL-C及HDL颗粒浓度与PAD的关联强于与冠状动脉和脑血管疾病的关联。
- 在TC:HDL-C基础上加入LDL颗粒和HDL颗粒浓度可识别PAD风险增高的女性。
关键数值与推荐
- 症状性PAD定义为跛行和/或血运重建,共110例。
- 极端三分位比较的多变量校正HRadj:总LDL颗粒2.03(95%CI 1.14-3.59),小LDL颗粒2.17(95%CI 1.10-4.27),极大型VLDL颗粒1.68(95%CI 1.06-2.66),中型VLDL颗粒1.98(95%CI 1.15-3.41),TC:HDL-C 3.11(95%CI 1.67-5.81)。
- HDL-C极端三分位HRadj 0.30(P趋势<0.0001),HDL颗粒浓度HRadj 0.29(P趋势<0.0001)。
临床怎么用
- 在评估PAD风险时,除标准血脂外可关注LDL颗粒、VLDL颗粒亚类及HDL颗粒浓度等核磁共振指标。
- TC:HDL-C升高、富含甘油三酯脂蛋白升高及低HDL颗粒浓度提示PAD风险增加。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Despite strong and consistent prospective associations of elevated low-density lipoprotein (LDL) cholesterol concentration with incident coronary and cerebrovascular disease, data for incident peripheral artery disease (PAD) are less robust. Atherogenic dyslipidemia characterized by increased small LDL particle (LDL-P) concentration, rather than total LDL cholesterol content, along with elevated triglyceride-rich lipoproteins and low high-density lipoprotein (HDL) cholesterol (HDL-C), may be the primary lipid driver of PAD risk. METHODS: The study population was a prospective cohort study of 27 888 women ≥45 years old free of cardiovascular disease at baseline and followed for a median of 15.1 years. We tested whether standard lipid concentrations, as well as nuclear magnetic resonance spectroscopy-derived lipoprotein measures, were associated with incident symptomatic PAD (n=110) defined as claudication and/or revascularization. RESULTS: In age-adjusted analyses, while LDL cholesterol was not associated with incident PAD, we found significant associations for increased total and small LDL-P concentrations, triglycerides, and concentrations of very LDL (VLDL) particle (VLDL-P) subclasses, increased total cholesterol (TC):HDL-C, low HDL-C, and low HDL particle (HDL-P) concentration (all P for extreme tertile comparisons <0.05). Findings persisted in multivariable-adjusted models comparing extreme tertiles for elevated total LDL-P (adjusted hazard ratio [HRadj] 2.03; 95% CI, 1.14-3.59), small LDL-P (HRadj 2.17; 95% CI, 1.10-4.27), very large VLDL-P (HRadj 1.68; 95% CI, 1.06-2.66), medium VLDL-P (HRadj 1.98; 95% CI, 1.15-3.41), and TC:HDL-C (HRadj, 3.11; 95% CI, 1.67-5.81). HDL was inversely associated with risk; HRadj for extreme tertiles of HDL-C and HDL-P concentration were 0.30 ( P trend < 0.0001) and 0.29 ( P trend < 0.0001), respectively. These components of atherogenic dyslipidemia, including small LDL-P, medium and very large VLDL-P, TC:HDL-C, HDL-C, and HDL-P, were more strongly associated with incident PAD than incident coronary and cerebrovascular disease. Finally, the addition of LDL-P and HDL-P concentration to TC:HDL-C measures identified women at heightened PAD risk. CONCLUSIONS: In this prospective study, nuclear magnetic resonance-derived measures of LDL-P, but not LDL cholesterol, were associated with incident PAD. Other features of atherogenic dyslipidemia, including elevations in TC:HDL-C, elevations in triglyceride-rich lipoproteins, and low standard and nuclear magnetic resonance-derived measures of HDL, were significant risk determinants. These data help clarify prior inconsistencies and may elucidate a unique lipoprotein signature for PAD compared to coronary and cerebrovascular disease. CLINICAL TRIAL REGISTRATION: URL: https://www.clinicaltrials.gov/ . Unique Identifier: NCT00000479.
引用
- Aday AW, Lawler PR, Cook NR, et al. Lipoprotein Particle Profiles, Standard Lipids, and Peripheral Artery Disease Incidence. Circulation. 2018. PMID: 30021845. doi:10.1161/CIRCULATIONAHA.118.035432
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。